Literature DB >> 23361280

A comparative analysis of langerhans cell in oral epithelial dysplasia and oral squamous cell carcinoma using antibody CD-1a.

Juhi Upadhyay1, Nirmala N Rao, Ram B Upadhyay.   

Abstract

BACKGROUND: The integrity of the immune system is necessary to control tumor progression and a compromised state contributes to tumor escape. AIMS: The study intends to evaluate the presence and distribution pattern of Langerhans cells (LC) in Oral epithelial dysplasia (OED) and oral squamous cell carcinoma (OSCC) oral epithelial dysplasia and oral squamous cell carcinoma and elucidate their role. The study analyses LC in histological zones of the epithelium and connective tissue, which has seldom been attempted previously.
MATERIALS AND METHODS: Forty-five microscopic sections (i.e. 5 normal, 15 OED and 25 OSCC) were examined for expression of LC marker CD1a using immunohistochemistry. LCs were counted in zones of epithelium and connective tissue. STATISTICAL ANALYSIS USED: Results were analyzed using SPSS Version 16.0 and subjected to one-way ANOVA comparison and Student's t-test and Wilcoxon Z test.
RESULTS: Significant decline in LC count was observed with progressing grade of OED and OSCC. The basal and suprabasal zones in OED and superficial zone in OSCC exhibited the highest density of LCs. The low LC count in severe dysplasia was attributed to paucity in the basal zone. There was a significant paucity of LCs in the sub-epithelial zone of all the grades of OSCC, with high influx of LCs within the tumor stroma. Also, poorly differentiated OSCC exhibited a significant decrease in the LC count within the overlying epithelium as well as the tumor stroma.
CONCLUSION: The present study suggests that there is a recruitment of LCs in the neoplastic process. Changes observed in LC distribution within the zones of dysplastic epithelium and tumor stroma can be interpreted as their pathophysiologic function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23361280     DOI: 10.4103/0973-1482.106565

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  7 in total

1.  A Comparative Immunohistochemical Analysis of Langerhans Cells in Oral Mucosa, Oral Lichen Planus and Oral Squamous Cell Carcinoma.

Authors:  Aruna Kumari Maloth; Shyam Prasad Reddy Dorankula; Ajay Prakash Pasupula; Madhusudan Rao Thokala; Keerthi Muddana; Ravinder Ramavath
Journal:  J Clin Diagn Res       Date:  2015-07-01

2.  Niche rather than origin dysregulates mucosal Langerhans cells development in aged mice.

Authors:  Yael Horev; Rana Salameh; Maria Nassar; Tal Capucha; Yasmin Saba; Or Barel; Khaled Zubeidat; Daniela Matanes; Amit Leibovich; Oded Heyman; Luba Eli-Berchoer; Salem Hanhan; Gili Betser-Cohen; Hagit Shapiro; Eran Elinav; Herve Bercovier; Asaf Wilensky; Avi-Hai Hovav
Journal:  Mucosal Immunol       Date:  2020-05-26       Impact factor: 7.313

Review 3.  The Current Understanding on Langerhans' Cells and Its Role in Oral Lesions.

Authors:  Vidyadevi Chandavarkar; Mithilesh N Mishra; R Sangeetha; B R Premalatha
Journal:  Contemp Clin Dent       Date:  2020-11-26

4.  Laser Therapy Inhibits Tumor Growth in Mice by Promoting Immune Surveillance and Vessel Normalization.

Authors:  Giulia Ottaviani; Valentina Martinelli; Katia Rupel; Nicoletta Caronni; Asma Naseem; Lorenzo Zandonà; Giuseppe Perinetti; Margherita Gobbo; Roberto Di Lenarda; Rossana Bussani; Federica Benvenuti; Mauro Giacca; Matteo Biasotto; Serena Zacchigna
Journal:  EBioMedicine       Date:  2016-07-25       Impact factor: 8.143

5.  Melanomas and Dysplastic Nevi Differ in Epidermal CD1c+ Dendritic Cell Count.

Authors:  Grzegorz Dyduch; Katarzyna Ewa Tyrak; Anna Glajcar; Joanna Szpor; Magdalena Ulatowska-Białas; Krzysztof Okoń
Journal:  Biomed Res Int       Date:  2017-02-26       Impact factor: 3.411

6.  Role of abnormal Langerhans cells in oral epithelial dysplasia and oral squamous cell carcinoma: A pilot study.

Authors:  Shyamsundar Vidya Rani; Babu Aravindha; Sankari Leena; Nandagopal Balachander; Letchumana Kumar Malathi; Mahaboob Kadar Masthan
Journal:  J Nat Sci Biol Med       Date:  2015-08

7.  CD207+/langerin positive dendritic cells in invasive and in situ cutaneous malignant melanoma.

Authors:  Grzegorz Dyduch; Katarzyna E Tyrak; Anna Glajcar; Joanna Szpor; Krzysztof Okoń
Journal:  Postepy Dermatol Alergol       Date:  2017-05-29       Impact factor: 1.837

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.